AIDS News and Research

RSS

New compounds for the treatment of HIV/AIDS

Scientists from Tibotec Pharmaceuticals Ltd. presented data on several new compounds for the treatment of HIV/AIDS at the 12th Conference on Retroviruses and Opportunistic Infections (CROI), held February 22-25 in Boston, MA, USA.

27 Feb 2005

Scientists identify immune-system mutation

A team of Fox Chase Cancer Center scientists led by immunologist Dietmar J. Kappes, Ph.D., has identified the genetic mutation that keeps a mouse strain from developing white blood cells, or lymphocytes, called helper T cells. The report by Kappes and his colleagues appears in the Feb. 24 issue of Nature.

27 Feb 2005

Gel provides protection from HIV and herpes

Mount Sinai School of Medicine researchers demonstrated that a gel applied in the vagina provides protection from both the human immunodeficiency virus (HIV) and the herpes simplex Virus. The study, presented at the 12th Conference on Retroviruses and Opportunistic Infections, is the first to show that a gel can retain anti-viral activity within the human vagina.

27 Feb 2005

New York City Health statement on rare strain of HIV in a New York City resident

On February 11, 2005, the New York City Department of Health and Mental Hygiene (DOHMH) reported a case of HIV infection with a strain that is resistant to many drugs in three classes of HIV medications, and which appears to have progressed to AIDS within 4 to 20 months after infection.

27 Feb 2005

Discrimination disguised as public health policy

UK opposition-party leader Michael Howard announced last week that his party would deny visas to prospective immigrants who test positive for tuberculosis (TB). HIV tests would also be mandatory under the Conservative policy.

27 Feb 2005

NIH awards grant to explore causal relationship between epoetin dose and survival of hemodialysis patients

The National Institutes of Health, National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) has awarded a two-year grant to the Medical Technology and Practice Patterns Institute (MTPPI) in collaboration with Harvard School of Public Health (HSPH) to explore the causal relationship between epoetin dose and survival of hemodialysis patients receiving this therapy.

27 Feb 2005

Cutting edge technology identifies genes that are involved in the development of Alzheimer's disease

Phoenix-Researchers at the Translational Genomics Research Institute (TGen) and Kronos Science Laboratories, an affiliate of Phoenix-based Kronos Optimal Health Company, have initiated a study with unprecedented power to identify genes that are involved in the development of Alzheimer's disease, the most common form of disabling memory and thinking problems in older persons.

24 Feb 2005

South Africa explores faith-based healing

The South African Department of Health met with religious leaders in Johannesburg on Monday (21 February 2005) to discus areas of cooperation between the Department and faith-based organisations in improving health of South African nation.

23 Feb 2005

New information that may help guide design of vaccines for HIV-1

Scientists have uncovered new information that may help guide design of vaccines for HIV-1, the virus that causes AIDS. A new detailed structural analysis of the complex formed by an anti-HIV antibody called 4E10 and its specific target provides insight into why this particular antibody is so broadly effective, a rare characteristic for HIV discovered thus far.

22 Feb 2005

Antibody that neutralizes most HIV strains

A group of scientists from The Scripps Research Institute and several other institutions has solved the structure of a rare human antibody that broadly neutralizes human immunodeficiency virus (HIV), which causes acquired immunodeficiency syndrome (AIDS).

22 Feb 2005

Innovative HIV/STD prevention program targets Guinean gold mining camps

A common, yet risky practice among gold miners in rural Guinea to engage in short "marriages" with women working briefly at the mine is the target of an innovative health communication program that educates both women and miners about how to prevent HIV and other sexually transmitted diseases.

22 Feb 2005

Benitec announces AIDS collaboration

Benitec today announced a collaboration with City of Hope (based in Duarte California) to develop a novel T-cell based therapy for AIDS patients.

22 Feb 2005

Prospects for a safe, effective AIDS vaccine are improving

Prospects for a safe, effective AIDS vaccine are improving as researchers from the public and private sectors begin to collaborate in new and creative ways, researchers said recently at the 2005 Annual Meeting of the American Association for the Advancement of Science (AAAS).

22 Feb 2005

Biochemical marker aids prognosis in liver transplant patients

A new study on whether the model used to identify patients most in need of a liver transplant can be improved upon found that measuring serum sodium in potential transplant patients helps to better predict those with a poor prognosis.

20 Feb 2005

$5.53 million to help strengthen Canada's nursing workforce

Canadian Health Minister Ujjal Dosanjh has announced federal funding of $5.53 million to help strengthen Canada's nursing workforce paying tribute to the critical role nurses play in Canada's health care system. Minister Dosanjh made this announcement in a speech to the Nursing Leadership Conference.

17 Feb 2005

EuroVacc 02 HIV Vaccine trial begins

The European Vaccine Effort against HIV/AIDS, has announced that a phase I clinical trial of novel investigational vaccines comprising DNA-HIV-C and NYVAC-HIV-C for the prevention of HIV infection has started in Lausanne and London in February 2005.

16 Feb 2005

Patent-based regulation of genetic resources could undermine health in developing countries

The Australian APEC Study Centre has released a report showing how proposals for a patent-based regime to regulate access to genetic resources could inhibit efforts to protect biodiversity and undermine health in developing countries.

14 Feb 2005

Blips and AIDS therapy

Researchers at Johns Hopkins have concluded that sudden, temporary spikes in the amount of HIV in the body, commonly called blips, do not always mean the virus is developing resistance to AIDS drugs.

14 Feb 2005

New 3-DCR HIV strain does not respond to three classes of anti-retroviral medication

A highly resistant strain of rapidly progressive human immunodeficiency virus (HIV) has been diagnosed for the first time in a New York City resident who had not previously undergone antiviral drug treatment, according to the Department of Health and Mental Hygiene (DOHMH).

13 Feb 2005

Two-step approach to transform HIV into a cancer-seeking machine

Camouflaging an impotent AIDS virus in new clothes enables it to hunt down metastasized melanoma cells in living mice, reports a UCLA AIDS Institute study in the Feb. 13 online edition of Nature Medicine.

13 Feb 2005